Shares Homepage - BSE Sensex, NSE Nifty, Latest Prices, Live News, Company Search, Result Annoucements, Company News, Top stories, Gainers Losers, Top Performers, Market Commentary, Live Quotes, Bulk Deals
India's preferred Personal finance destination
Home Shares News Centre F&O Mutual Funds IPO Portfolio Commodity Loans Financial Planning Insurance About Us
Markets Companies Research Industries E-Mail Page
Wealth Tracker      Tax Corner NRI Centre Chat Masala Feedback
my Last 5 Scrips
Company BSE Price(Rs) % Chg
Hindalco 148.45 0.27
Bhel 242.00 1.89
Ong Corp 400.05 1.97
Tata Stl 457.10 0.29
Tata Mot 519.45 3.54
Clear All Clear Last
Shares
NSE Live
Nifty Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
BSE Live
BSE30 Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
IPO Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Discussion Forum
Research
Research Reports
Sector Watch
Economy Watch
Snapshot-Anuh Pharma Limited
Anuh Pharma Limited
Sector:Pharmaceuticals Pharmaceuticals - Formulations
BSE:506260NSE:NABloomberg:ANUH@INReuters:ANUH.BO
Market Lot: 1Face Value: 5ISIN Demat: INE489G01022
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

 
 
Recent Developments
10-APR-14 Anuh Pharma has received approval from COFEPRIS (Health Authority of Mexico) GMP certificate for three of company's Erythromycin products. 06-AUG-10 Anuh Pharma, engaged in manufacturing and marketing of bulk drugs and chemicals today announced that it has approved issue of bonus shares in the ratio of 1:2, subject to permission of members. 23-JUN-10 Anuh Pharma engaged in the manufacture, marketing and export of bulk drugs and anti...   More..
Business Profile Future Plans
One To One
Recent news
Latest News
Anuh Pharma surges on nod from COFEPRIS   -IRIS 10-Apr-14
Previous

More


Brief Financials (in Rs. Mn.) 
Period ending (months)30-Jun-2014(3)31-Mar-2014 (12)31-Mar-2013 (12)
Net sales 753.372663.982426.71
Other Income12.155.611.23
Total Income765.522669.592427.94
Cost of goods sold667.332396.322234.00
OPBDIT98.19273.27193.94
PAT65.62175.90125.35
Gross Block---
Equity capital41.7641.7641.76
EPS (Rs.)-21.0615.01
DPS (Rs.)---
BV (Rs.)---
P/E range (x)-4.99 - 8.027.49 - 10.93
Debt / Equity (x)---
Operating margin (% of OI)12.810.2 8.0
Net margin (% of OI) 8.6 6.6 5.2
Detailed Financials
Income 
Statement
Balance Sheet Latest 
Quarterly/Halfyearly
Ratio Analysis Share Statistics
Price Charts
Scrip Information



Registered Office
ADDRESS
3 - A, Shiv Sagar Estate
North Wing
Dr. Annie Besant Road
Worli
Mumbai
Maharashtra-400 018
PHONE
(022) 6622 7575
FAX
(022) 6622 7500
 
Board of Directors
NSE/BSE Announcements


Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Wealth Tracker | Tax Corner | NRI Centre | Search in myiris | Advertise
All rights reserved. IRIS Business Services Limited
Disclaimer